153710 — Optipharm Co Balance Sheet
0.000.00%
- KR₩72bn
- KR₩73bn
- KR₩20bn
- 49
- 15
- 14
- 11
Annual balance sheet for Optipharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 22,025 | 21,187 | 16,073 | 14,654 | 14,022 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1,290 | 1,338 | 2,292 | 1,880 | 1,580 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 25,676 | 25,867 | 21,548 | 20,476 | 18,675 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 13,347 | 13,613 | 17,717 | 18,325 | 23,789 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 41,321 | 41,168 | 41,182 | 39,275 | 43,319 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 5,524 | 7,851 | 9,264 | 11,601 | 12,734 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 7,541 | 10,213 | 12,171 | 14,131 | 15,983 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| ESOP Debt Guarantee | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 33,780 | 30,955 | 29,011 | 25,144 | 27,335 |
| Total Liabilities & Shareholders' Equity | 41,321 | 41,168 | 41,182 | 39,275 | 43,319 |
| Total Common Shares Outstanding |